Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Pete, GSK and Vir Biotechnology has a treatment that's pretty promising.

The companies said late on Wednesday that the monoclonal-antibody drug — VIR-7831 — reduced death or hospitalization by 85% compared with a placebo in a clinical trial. Following the results, Vir and GSK said they plan to submit an Emergency Use Authorization application to the U.S. Food and Drug Administration as well as regulators in other countries.

Glaxo and Vir said that an independent monitoring committee recommended the late-stage trial — for early treatment of COVID-19 in adults at high risk of hospitalization — be stopped early because interim analysis showed the drug to be highly effective. The recommendation is based on data from 583 patients but the companies didn’t disclose detailed results

A separate in vitro study showed the drug remains effective against new coronavirus variants identified in the U.K., South Africa and Brazil, they added

https://www.marketwatch.com/story/vir-surges-38-after-covid-19-antibody-drug-shown-to-reduce-risk-of-death-11615462587

I will be shocked if any decent vaccine/treatment comes out of them.